Waters Offers U.S. Water Authorities Complimentary Drinking Water Testing for the Presence of Pharmaceuticals

... Baseline Understanding of Exposure Allows for Long-term Monitoring ... Development of Solutions ...MILFORD Mass. March 19 /- Responding to recen... As a provider of analytical technologies capable of detecting tracel...

Baseline Understanding of Exposure Allows for Long-term Monitoring and

Development of Solutions

MILFORD, Mass., March 19 /PRNewswire-FirstCall/ -- Responding to recent
reports regarding findings of trace levels of pharmaceuticals found in U.S.
drinking water supplies, Waters Corporation (NYSE: WAT) announced today
that it will offer qualified U.S. water authorities complimentary drinking
water analysis for common over-the-counter and prescription antidepressant
pharmaceutical compounds to help assess regional exposure and move towards
forward-looking solutions.

"As a provider of analytical technologies capable of detecting trace
levels of contaminants in water, food and the environment, Waters(R) is
keenly aware of the broad impact that contaminants can have on our natural
resources," said Rohit Khanna, Vice President of Worldwide Marketing for
the Waters Division. "As scientists, we at Waters believe in the need - and
have the solutions - to assess baseline data to measure contamination
levels, if any. Through this program we hope to work in cooperation with
U.S. water authorities to better assess the public's exposure to
pharmaceutical residues and assist them with potential action plans."

For 50 years, Waters has been producing advanced environmental
solutions and working with regulatory and government agencies at all
levels. For example, the Associated Press reported that the U.S.
Environmental Protection Agency (EPA) recently published a method to test
for pharmaceutical and personal care products in water, soil, sediment, and
biosolids; a method which references Waters solutions throughout. More
recently, Waters is applying advance technology to deliver an automated
solution with improved throughput for drinking water analysis.

Program Logistics

For a limited time, Waters will offer authorized officials from any
U.S. water authority that serves more than 100,000 customers to submit a
request for a complimentary test for common over-the-counter and
anti-depressant pharmaceutical compounds of their finished water (tap
water) by visiting http://www.waters.com/h2o. Requests will only be honored
from authorized water officials and the results will be held in strict
confidence. Waters will not accept requests from third parties.

The intention of these tests is to provide a baseline understanding of
exposure to facilitate long-term solutions. These complimentary tests will
not be validated or certified, and are only intended as an initial screen
for the detection of pharmaceutical residues.

Waters Solutions

Waters will test submitted samples using the AquaAnalysis System, a
total system solution designed to detect a range of contaminants in
drinking water. The AquaAnalysis System can detect target analytes at or
below 10 parts-per- trillion (PPT), easily meeting or exceeding regulatory
standards worldwide. The AquaAnalysis System has been shown to improve
sample throughput by up to 80 percent by cutting analysis times from
between three to five hours to just 30 minutes.

In December 2007, EPA published Method 1694 Pharmaceuticals and
Personal Care Products in Water, Soil, Sediment, and Biosolids by
HPLC/MS/MS. Using Waters chemistry products, Method 1694 identifies
pharmaceuticals and personal care products in environmental samples by high
performance liquid chromatography combined with tandem mass spectrometry
(HPLC/MS/MS) using isotope dilution and internal standard quantification
techniques. This method has been developed for use with aqueous, solid, and
biosolids matrices:
(http://www.epa.gov/waterscience/methods/method/files/1694.pdf).

About Waters Corporation

Waters Corporation creates business advantages for laboratory-dependent
organizations by delivering practical and sustainable innovation to enable
significant advancements in such areas as healthcare delivery,
environmental management, food safety, and water quality worldwide.

(Date:12/9/2016)... ... December 09, 2016 , ... ... Pierre Hotel in New York, NY, on December 3rd, to benefit Holy Name ... attended the annual event, which raised over $1 million - the largest event ...

(Date:12/8/2016)... FL (PRWEB) , ... December 08, 2016 , ... ... awarded accreditation with distinction by the Undersea and Hyperbaric Medical Society (UHMS), the ... with advanced care and patient safety. Only a few hospitals and facilities have ...

(Date:12/8/2016)... -- KEY FINDINGS North America ... in 2016 and is expected to continue in the ... large number of surgical procedures that are taking place ... the patient temperature management market.) Patient warming and cooling ... blood during surgeries, lowering the risks of neurological disorders ...

(Date:12/8/2016)... 2016 Research and Markets has announced the ... - Adhesion Type, Application, Usability - Forecast to 2025" report ... , , ... is poised to grow at a CAGR of around 3.2% from ... is witnessing include advancements in extracellular microelectrode arrays and intracellular microelectrodes, ...